Matt O'Brien
Stock Analyst at Piper Sandler
(2.10)
# 2,992
Out of 5,241 analysts
209
Total ratings
41.04%
Success rate
-7.8%
Average return
Main Sectors:
Stocks Rated by Matt O'Brien
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SI Shoulder Innovations | Reiterates: Overweight | $18 → $19 | $14.93 | +27.26% | 3 | May 8, 2026 | |
| TMDX TransMedics Group | Maintains: Overweight | $160 → $120 | $66.13 | +81.46% | 15 | May 6, 2026 | |
| ATEC Alphatec Holdings | Reiterates: Overweight | $25 → $14 | $8.22 | +70.32% | 5 | May 6, 2026 | |
| ITGR Integer Holdings | Reiterates: Overweight | $87 → $97 | $90.44 | +7.25% | 4 | May 1, 2026 | |
| PRCT PROCEPT BioRobotics | Reiterates: Overweight | $28 → $35 | $25.91 | +35.08% | 7 | Apr 30, 2026 | |
| ADGM Adagio Medical Holdings | Initiates: Overweight | $3 | $0.835 | +259.28% | 1 | Apr 14, 2026 | |
| MDT Medtronic | Maintains: Neutral | $105 → $91 | $78.58 | +15.81% | 10 | Apr 1, 2026 | |
| MMED MiniMed Group | Initiates: Neutral | $16 | $10.88 | +47.13% | 1 | Mar 31, 2026 | |
| TELA TELA Bio | Maintains: Neutral | $1.25 → $1 | $0.86 | +16.28% | 8 | Mar 25, 2026 | |
| CNMD CONMED | Downgrades: Neutral | $55 → $39 | $36.18 | +7.79% | 15 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $21 → $33 | $13.86 | +138.10% | 11 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $90 → $115 | $79.93 | +43.88% | 13 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $27 → $30 | $19.80 | +51.52% | 2 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $75 | $66.95 | +12.02% | 13 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $26 → $32 | $9.42 | +239.70% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $22 | $18.23 | +20.68% | 3 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $11.29 | +59.43% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $12 | $6.01 | +99.67% | 9 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 → $165 | $139.90 | +17.94% | 10 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5.5 → $3.5 | $4.72 | -25.85% | 7 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $255 → $140 | $132.74 | +5.47% | 5 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $285 → $310 | $154.61 | +100.50% | 8 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $250 → $330 | $326.55 | +1.06% | 13 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $50 | $28.80 | +73.61% | 3 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $40 → $16 | $32.60 | -50.92% | 7 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $115 | $56.81 | +102.43% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $9 → $12 | $4.20 | +186.05% | 7 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $380 → $420 | $317.75 | +32.18% | 12 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $25 | $14.84 | +68.46% | 1 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $3 | $0.8253 | +263.50% | 2 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $4 → $4.5 | $3.94 | +14.21% | 2 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $86.08 | - | 2 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $4.00 | +275.00% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $93 → $109 | $61.45 | +76.97% | 1 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $100 → $80 | $18.33 | +336.44% | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $12 | $3.96 | +203.03% | 1 | Jun 24, 2020 |
Shoulder Innovations
May 8, 2026
Reiterates: Overweight
Price Target: $18 → $19
Current: $14.93
Upside: +27.26%
TransMedics Group
May 6, 2026
Maintains: Overweight
Price Target: $160 → $120
Current: $66.13
Upside: +81.46%
Alphatec Holdings
May 6, 2026
Reiterates: Overweight
Price Target: $25 → $14
Current: $8.22
Upside: +70.32%
Integer Holdings
May 1, 2026
Reiterates: Overweight
Price Target: $87 → $97
Current: $90.44
Upside: +7.25%
PROCEPT BioRobotics
Apr 30, 2026
Reiterates: Overweight
Price Target: $28 → $35
Current: $25.91
Upside: +35.08%
Adagio Medical Holdings
Apr 14, 2026
Initiates: Overweight
Price Target: $3
Current: $0.835
Upside: +259.28%
Medtronic
Apr 1, 2026
Maintains: Neutral
Price Target: $105 → $91
Current: $78.58
Upside: +15.81%
MiniMed Group
Mar 31, 2026
Initiates: Neutral
Price Target: $16
Current: $10.88
Upside: +47.13%
TELA Bio
Mar 25, 2026
Maintains: Neutral
Price Target: $1.25 → $1
Current: $0.86
Upside: +16.28%
CONMED
Mar 17, 2026
Downgrades: Neutral
Price Target: $55 → $39
Current: $36.18
Upside: +7.79%
Mar 17, 2026
Upgrades: Overweight
Price Target: $21 → $33
Current: $13.86
Upside: +138.10%
Jan 8, 2026
Reiterates: Overweight
Price Target: $90 → $115
Current: $79.93
Upside: +43.88%
Dec 12, 2025
Maintains: Overweight
Price Target: $27 → $30
Current: $19.80
Upside: +51.52%
Oct 31, 2025
Maintains: Overweight
Price Target: $100 → $75
Current: $66.95
Upside: +12.02%
Oct 29, 2025
Reiterates: Overweight
Price Target: $26 → $32
Current: $9.42
Upside: +239.70%
Oct 10, 2025
Maintains: Overweight
Price Target: $30 → $22
Current: $18.23
Upside: +20.68%
Aug 18, 2025
Initiates: Overweight
Price Target: $18
Current: $11.29
Upside: +59.43%
May 9, 2025
Maintains: Overweight
Price Target: $20 → $12
Current: $6.01
Upside: +99.67%
Apr 15, 2025
Maintains: Overweight
Price Target: $180 → $165
Current: $139.90
Upside: +17.94%
Mar 6, 2025
Maintains: Neutral
Price Target: $5.5 → $3.5
Current: $4.72
Upside: -25.85%
Feb 28, 2025
Downgrades: Neutral
Price Target: $255 → $140
Current: $132.74
Upside: +5.47%
Feb 21, 2025
Maintains: Overweight
Price Target: $285 → $310
Current: $154.61
Upside: +100.50%
Feb 19, 2025
Reiterates: Overweight
Price Target: $250 → $330
Current: $326.55
Upside: +1.06%
Feb 13, 2025
Maintains: Overweight
Price Target: $40 → $50
Current: $28.80
Upside: +73.61%
Feb 12, 2025
Maintains: Neutral
Price Target: $40 → $16
Current: $32.60
Upside: -50.92%
Feb 3, 2025
Maintains: Overweight
Price Target: $95 → $115
Current: $56.81
Upside: +102.43%
Nov 8, 2024
Reiterates: Neutral
Price Target: $9 → $12
Current: $4.20
Upside: +186.05%
Oct 30, 2024
Reiterates: Overweight
Price Target: $380 → $420
Current: $317.75
Upside: +32.18%
Mar 28, 2024
Initiates: Overweight
Price Target: $25
Current: $14.84
Upside: +68.46%
Nov 10, 2023
Maintains: Neutral
Price Target: $3.5 → $3
Current: $0.8253
Upside: +263.50%
Aug 11, 2023
Maintains: Overweight
Price Target: $4 → $4.5
Current: $3.94
Upside: +14.21%
Mar 10, 2023
Upgrades: Overweight
Price Target: n/a
Current: $86.08
Upside: -
Feb 24, 2023
Initiates: Overweight
Price Target: $15
Current: $4.00
Upside: +275.00%
Feb 11, 2021
Maintains: Overweight
Price Target: $93 → $109
Current: $61.45
Upside: +76.97%
Jan 29, 2021
Downgrades: Neutral
Price Target: $100 → $80
Current: $18.33
Upside: +336.44%
Jun 24, 2020
Initiates: Overweight
Price Target: $12
Current: $3.96
Upside: +203.03%